Recent advances in the molecular biology of Hepatitis C virus

Journal of Molecular Biology

Volumn 313, Issue 3, 2001, Pages 451-464

  Rosenberg, Steven ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antivirals; Hepatitis C virus; Infectious RNA; Interferon; Subgenomic replicons

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; NS3 HELICASE; NS3 PROTEASE; NS5B RNA DIRECTED RNA POLYMERASE; PROTEIN NS4B; PROTEOME; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN;

CHRONIC LIVER DISEASE; HEPATITIS C VIRUS; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPLICON; REVIEW; RNA VIRUS; SEQUENCE HOMOLOGY; VIRUS GENE; VIRUS REPLICATION;

EID: 0035955558     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5055     Document Type: Review

References (139)

1. Evolutionary relationship of hepatitis C, pesti-flavi- planviruses, and newly discovered GB hepatitis agents
2. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
3. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
4. Hepatitis C virus and its pathogenesis
5. Hepatitis C virus and liver transplantation
6. Viral, host, and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection
7. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C
8. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The hepatitis C intervention therapy group
9. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
10. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a
11. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA
12. A novel sequence found at the 3′ terminus of hepatitis C virus genome
13. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: Properties of the NS5A-associated kinase
14. Molecular virology of hepatitis C virus: An update with respect to potential antiviral targets
15. Replication of hepatitis C virus
16. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties
17. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
18. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
19. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo
20. Hepatitis C virus: An infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras
21. Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees
22. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo
23. In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone
24. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
25. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV
26. Transfection of HepG2 cells with infectious hepatitis C virus genome
27. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells
28. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
29. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
30. Efficient initiation of HCV RNA replication in cell culture
31. Mutations in hepatitis C virus RNAs conferring cell culture adaptation
32. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations
33. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs
34. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation
35. Kinetic and structural analyses of hepatitis C virus polyprotein processing
36. Expression and identification of hepatitis C virus polyprotein cleavage products
37. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome
38. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR
39. Proof of hepatitis A virus negative-sense RNA by RNA/DNA-hybrid detection: A method for specific detection of both viral negative- and positive-strand RNA species
40. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
41. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus
42. A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA
43. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus
44. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3′-terminal sequences of viral positive- and negative-strand RNA
45. Cellular proteins bind to the poly(U) tract of the 3′ untranslated region of hepatitis C virus RNA genome
46. Human hepatic glyceraldehyde-3-phosphate dehydrogenase binds to the poly(U) tract of the 3′ non-coding region of hepatitis C virus genomic RNA
47. The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3′ untranslated region
48. Translation of hepatitis C virus RNA
49. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation of hepatitis C virus RNA
50. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus
51. Mechanism of ribosome recruitment by hepatitis C IRES RNA
52. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40 s ribosomal subunit
53. The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold
54. Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function
55. Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach
56. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs
57. Hepatitis C virus core protein: Possible roles in viral pathogenesis
58. Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes
59. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation
60. Hepatitis C virus structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stably transfected cells
61. Characterization of aggregates of hepatitis C virus glycoproteins
62. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
63. Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain
64. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
65. Perspectives for a vaccine against hepatitis C virus
66. Cell fusion activity of hepatitis C virus envelope proteins
67. Binding of hepatitis C virus to CD81
68. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
69. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
70. The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy
71. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
72. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
73. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
74. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
75. Hepatitis C virus glycoprotein E2 binding to CD81: The role of E1E2 cleavage and protein glycosylation in bioactivity
76. Structure-function analysis of hepatitis C virus envelope-CD81 binding
77. CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs
78. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection
79. Hepatitis C virus-encoded NS2-3 protease: Cleavage-site mutagenesis and requirements for bimolecular cleavage
80. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus
81. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site
82. In vitro study of the NS2-3 protease of hepatitis C virus
83. Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein
84. The NS3/4A proteinase of the hepatitis C virus: Unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
85. Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites
86. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity
87. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A
88. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
89. Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes
90. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase
91. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism
92. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex
93. Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion
94. Converting trypsin to chymotrypsin: The role of surface loops
95. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A
96. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain
97. Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing
98. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus
99. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex
100. Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain
101. Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor
102. The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase
103. Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors
104. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase
105. Peptide-based inhibitors of the hepatitis C virus serine protease
106. Product inhibition of the hepatitis C virus NS3 protease
107. A personal account of the role of peptide research in drug discovery: The case of hepatitis C
108. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes
109. Structure and function of hepatitis C virus NS3 helicase
110. A kinetic analysis of the oligonucleotide-modulated ATPase activity of the helicase domain of the NS3 protein from hepatitis C virus. The first cycle of interaction of ATP with the enzyme is unique
111. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells
112. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding
113. Structure of the hepatitis C virus RNA helicase domain
114. Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA
115. The helicase from hepatitis C virus is active as an oligomer
116. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3
117. Hepatitis C virus core protein interacts with cellular putative RNA helicase
118. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase
119. Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: Implications for viral replication and in vitro assays
120. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
121. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
122. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
123. A mechanism for initiating RNA-dependent RNA polymerization
124. De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus
125. De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase
126. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP
127. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein
128. The hepatitis C virus NS4A protein: Interactions with the NS4B and NS5A proteins
129. The Hepatitis C virus non-structural Protein 4B is an integral endoplasmic reticulum membrane protein
130. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B
131. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
132. Hepatitis C virus non-structural 5a protein as a therapeutic target
133. The non-structural 5A protein of hepatitis C virus
134. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis
135. A genomic approach of the hepatitis C virus generates a protein interaction map
136. Crystal structure of the ribosome at 5.5 resolution
137. Structural basis of transcription: RNA polymerase II at 2.8 Å resolution
138. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus
139. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus